An Open-label Study Assessing Long-term Safety of DRM04 in Subjects With Primary Axillary Hyperhidrosis
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Glycopyrrolate (Primary)
- Indications Hyperhidrosis
- Focus Adverse reactions; Registrational
- Acronyms ARIDO
- Sponsors Dermira
- 13 Oct 2017 Results presented in a Dermira media release.
- 13 Oct 2017 Results from this trial were presented at the 36th Annual Fall Clinical Dermatology Conference, according to a Dermira media release.
- 12 Jan 2017 Status changed from active, no longer recruiting to completed.